PulseSight Therapeutics
Paris
About PulseSight Therapeutics
PulseSight is an ophthalmology drug development company creating novel, non-viral gene therapies with minimally invasive delivery technology to address the unmet need for treatments against severe retinal diseases leading to blindness.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Funding stage: Early Stage Venture
- Last round: Series A (Feb 2025)
- Website: pulsesight.com
- Phone: +33 (0)1 84 79 10 60
Industries & Categories
Biotechnology, Medical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/pulsesight-therapeutics-2240191 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.